Patents-Review.com
ClassID:

109050 ⎘

C12N15/1132 - CPC Classification

Classification description:

Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides against viruses against retroviridae, e.g. HIV

Recent Application in this class:
#1
20250360083
2025-11-27

LIPID NANOPARTICLE FORMULATIONS AND METHODS OF USE THEREOF

 #2
20250250562
2025-08-07

TAT-INDUCED CRISPR/ENDONUCLEASE-BASED GENE EDITING

 #3
20250121051
2025-04-17

HIV PRE-IMMUNIZATION AND IMMUNOTHERAPY

 #4
20250121050
2025-04-17

METHODS OF PRODUCING CELLS RESISTANT TO HIV INFECTION

 #5
20250101429
2025-03-27

siRNAs and shRNAs Targeting HIV and Combinations, Expression Cassettes, Cells and Use Thereof

 #6
20250057884
2025-02-20

Chimeric Antigen Receptor-T Cells Targeting HIV-Infected Cells

 #7
20250017181
2025-01-16

Multiplexed Genome Editing

 #8
20240301424
2024-09-12

MANIPULATED IMMUNOREGULATORY ELEMENT AND IMMUNITY ALTERED THEREBY

 #9
20240261436
2024-08-08

GENE EDITING THERAPY FOR HIV INFECTION VIA DUAL TARGETING OF HIV GENOME AND CCR5

 #10
20240240186
2024-07-18

COMB SHAPED ANTIVIRALS ENDING WITH OR WITHOUT CHAIN TERMINATING BASES

 #11
20240238406
2024-07-18

HIV PRE-IMMUNIZATION AND IMMUNOTHERAPY

 #12
20240108714
2024-04-04

PRE-IMMUNIZATION AND IMMUNOTHERAPY

 #13
20240091339
2024-03-21

PRE-IMMUNIZATION AND IMMUNOTHERAPY

 #14
20240076661
2024-03-07

LgRNA-directed CRISPR Gene Editing

 #15
20240000824
2024-01-04

OLIGONUCLEOTIDES CONTAINING 2'-DEOXY-2'FLUORO-BETA-D-ARABINOSE NUCLEIC ACID (2'-FANA) FOR TREATMENT AND DIAGNOSIS OF RETROVIRAL DISEASES

 #16
20230313193
2023-10-05

METHODS AND COMPOSITIONS FOR CRISPR/CAS9 GUIDE RNA EFFICIENCY AND SPECIFICITY AGAINST GENETICALLY DIVERSE HIV-1 ISOLATES

 #17
20230310594
2023-10-05

METHODS OF TREATING A LATENT HIV-1 INFECTION USING NON-CODING DEOXYRIBONUCLEIC ACIDS

 #18
20230279398
2023-09-07

TREATING HUMAN T-CELL LEUKEMIA VIRUS BY GENE EDITING

 #19
20230241200
2023-08-03

HIV PRE-IMMUNIZATION AND IMMUNOTHERAPY

 #20
20230193257
2023-06-22

TAT-INDUCED CRISPR/ENDONUCLEASE-BASED GENE EDITING

 #21
20230048681
2023-02-16

COMPOSITIONS AND METHODS OF TREATMENT FOR LYTIC AND LYSOGENIC VIRUSES

 #22
20220402978
2022-12-22

POLYPEPTIDES MIMICKING EPITOPE OF BROADLY NEUTRALIZING ANTIBODY VRC01 AS ANTIGENS FOR A VACCINE PREVENTING HIV-1 INFECTION

 #23
20220348958
2022-11-03

Enhancing Production of Lentiviral Vectors

 #24
20220332799
2022-10-20

HERV INHIBITORS FOR USE IN TREATING TAUOPATHIES

 #25
20220154188
2022-05-19

COMPOSITIONS AND METHODS FOR IN VIVO EXCISION OF HIV-1 PROVIRAL DNA

 #26
20220154187
2022-05-19

INTRODUCING SILENCING ACTIVITY TO DYSFUNCTIONAL RNA MOLECULES AND MODIFYING THEIR SPECIFICITY AGAINST A GENE OF INTEREST

 #27
20220145406
2022-05-12

BIOMARKERS, AND USES IN TREATMENT OF VIRAL INFECTIONS, INFLAMMATIONS, OR CANCER

 #28
20210363530
2021-11-25

Splice inhibiting oligonucleotides

 #29
20210330783
2021-10-28

HIV pre-immunization and immunotherapy

 #30
20210269804
2021-09-02

MULTIPLEXED SHRNAS AND USES THEREOF

 #31
20210222165
2021-07-22

Chemically Ligated RNAs for CRISPR/Cas9-lgRNA Complexes as Antiviral Therapeutic Agents

 #32
20210121561
2021-04-29

Methods of producing cells resistant to HIV infection

 #33
20210101963
2021-04-08

Broadly neutralizing anti-HIV-1 antibodies that bind to an N-glycan epitope on the envelope

 #34
20210100225
2021-04-08

Multiplexed genome editing

 #35
20210054411
2021-02-25

Use of ANP32 protein in maintaining the polymerase activity of influenza virus in hosts

 #36
20210054054
2021-02-25

Engineering pH-dependent antigen binding activity into anti-HIV antibodies with improved pharmacokinetics

 #37
20210052709
2021-02-25

Methods and compositions for RNA-guided treatment of HIV infection

 #38
20210032627
2021-02-04

GENE THERAPEUTIC FOR THE TREATMENT OF HIV AND USES THEREOF

 #39
20210009262
2021-01-14

Tetracyclic heterocycle compounds useful as HIV integrase inhibitors

 #40
20200392487
2020-12-17

EXCISION OF RETROVIRAL NUCLEIC ACID SEQUENCES

 #41
20200384021
2020-12-10

HIV IMMUNOTHERAPY WITH NO PRE-IMMUNIZATION STEP

 #42
20200339994
2020-10-29

Treatment of HIV

 #43
20200282025
2020-09-10

Methods and compositions for RNA-guided treatment of HIV infection

 #44
20200230234
2020-07-23

Methods of treating a retroviral infection

 #45
20200216850
2020-07-09

Splice inhibiting oligonucleotides

 #46
20200185071
2020-06-11

FACILITATING SEXUALLY TRANSMITTED INFECTION SERVICES

 #47
20200181621
2020-06-11

Compositions and methods for inhibition of the lncRNA SAF to drive apoptotic cell death in human immunodeficiency virus (HIV) infected human macrophages

 #48
20200170229
2020-06-04

Multiplexed genome editing

 #49
20200140865
2020-05-07

AN HIV-1 ERADICATION STRATEGY EMPLOYING NANOFORMULATED ANTI-RETROVIRAL DRUGS AND GENE EDITING AGENTS

 #50
20200109417
2020-04-09

HIV pre-immunization and immunotherapy

 #51
20200095586
2020-03-26

COMPOSITIONS AND METHODS OF TREATMENT FOR LYTIC AND LYSOGENIC VIRUSES

 #52
20200093917
2020-03-26

Method of inducing an immune response against human immunodeficiency virus by co-localized administration of vaccine components

 #53
20200030361
2020-01-30

OLIGONUCLEOTIDES CONTAINING 2'-DEOXY-2'FLUORO-BETA-D-ARABINOSE NUCLEIC ACID (2'-FANA) FOR TREATMENT AND DIAGNOSIS OF RETROVIRAL DISEASES

 #54
20200002776
2020-01-02

Methods of Detecting Lentivirus

 #55
20190367924
2019-12-05

GENE EDITING THERAPY FOR HIV INFECTION VIA DUAL TARGETING OF HIV GENOME AND CCR5

 #56
20190359987
2019-11-28

Composition and method for oligonucleotide delivery

 #57
20190351070
2019-11-21

COMPOSITIONS FOR THE INACTIVATION OF VIRUS REPLICATION AND METHODS OF MAKING AND USING THE SAME

 #58
20190350177
2019-11-21

Multiplexed genome editing

 #59
20190330635
2019-10-31

ANTIVIRAL AGENT AND METHOD FOR TREATING VIRAL INFECTION

 #60
20190315769
2019-10-17

Tetracyclic heterocycle compounds useful as HIV integrase inhibitors

 #61
20190225963
2019-07-25

Excision of retroviral nucleic acid sequences

 #62
20190218573
2019-07-18

HIV pre-immunization and immunotherapy

 #63
20190201523
2019-07-04

HIV pre-immunization and immunotherapy

 #64
20190185860
2019-06-20

Manipulated immunoregulatory element and immunity altered thereby

 #65
20190134195
2019-05-09

COMPOSITIONS AND METHODS FOR THE TREATMENT OF HUMAN PAPILLOMAVIRUS (HPV)-ASSOCIATED DISEASES

 #66
20190085334
2019-03-21

TREATMENT OF NEUROINFLAMMATION IN NEUROLOGICAL DISORDERS

 #67
20190085333
2019-03-21

Antiviral proteins and their uses in therapeutic methods

 #68
20190048067
2019-02-14

Broadly neutralizing anti-HIV-1 antibodies that bind to an N-glycan epitope on the envelope

 #69
20190046633
2019-02-14

Method of producing cells resistant to HIV infection

 #70
20190040393
2019-02-07

Managing Intercellular Communications

 #71
20190032057
2019-01-31

METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION

 #72
20190002883
2019-01-03

Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell

 #73
20180305688
2018-10-25

Chemically ligated RNAs for CRISPR/Cas9-1gRNA complexes as antiviral therapeutic agents

 #74
20180296649
2018-10-18

Methods and compositions for RNA-guided treatment of HIV infection

 #75
20180291399
2018-10-11

HIV pre-immunization and immunotherapy

 #76
20180288983
2018-10-11

Multiplexed genome editing

 #77
20180251858
2018-09-06

Method for identification of anti-HIV human miRNA mimics and miRNA inhibitors and anti-HIV pharmaceutical compounds

 #78
20180230491
2018-08-16

Method for expression of small RNA molecules within a cell

 #79
20180221393
2018-08-09

CXCR4 BINDING AGENTS FOR TREATMENT OF DISEASES

 #80
20180208914
2018-07-26

LENTIVIRUS AND NON-INTEGRATING LENTIVIRUS AS VIRAL VECTOR TO DELIVER CRISPR THERAPEUTIC

 #81
20180171361
2018-06-21

Multiplexed genome editing

 #82
20180155365
2018-06-07

Tetracyclic heterocycle compounds useful as HIV integrase inhibitors

 #83
20180125878
2018-05-10

Continuously expressed therapeutic RNAs for targeted protein binding and methods for their use

 #84
20180119147
2018-05-03

RNA amidates and thioamidates for RNAi

 #85
20180112220
2018-04-26

GENE THERAPEUTIC FOR THE TREATMENT OF HIV AND USES THEREOF

 #86
20180112219
2018-04-26

Compositions comprising TALENs and methods of treating HIV

 #87
20180080022
2018-03-22

Catalytic strands of minimal hammerhead ribozymes and methods of using the same

 #88
20180073018
2018-03-15

COMPOSITIONS AND METHODS FOR SPECIFIC REACTIVATION OF HIV LATENT RESERVOIR

 #89
20180010147
2018-01-11

HIV pre-immunization and immunotherapy

 #90
20170369951
2017-12-28

Method for identification of anti-HIV human miRNA mimics and miRNA inhibitors and anti-HIV pharmaceutical compounds

 #91
20170298357
2017-10-19

Treatment of HIV

 #92
20170283802
2017-10-05

DESIGN OF NUCLEIC ACID BINDING MOLECULES WITH NON-WATSON CRICK AND NON-CANONICAL PAIRING BASED ON ARTIFICIAL MUTATION CONSENSUS SEQUENCES TO COUNTER ESCAPE MUTATIONS

 #93
20170247703
2017-08-31

ANTIVIRAL NUCLEASE METHODS

 #94
20170240899
2017-08-24

Multiplexed shRNAs and uses thereof

 #95
20170211069
2017-07-27

Use of the chromosome 19 microRNA cluster (C19MC) for treating microbial disease and promoting authophagy

 #96
20170191059
2017-07-06

NUCLEIC ACIDS ACTING AS DECOYS FOR THE TREATMENT OF LENTIVIRUS INFECTION

 #97
20170130228
2017-05-11

Compositions and methods to activate or inhibit toll-like receptor signaling

 #98
20170121708
2017-05-04

Multifunctional RNA nanoparticles and methods of use

 #99
20170107519
2017-04-20

Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell

 #100
20170073684
2017-03-16

Cell-type specific aptamer-siRNA delivery system for HIV-1 therapy

 #101
20170049909
2017-02-23

Compositions for the inactivation of virus replication and methods of making and using the same

 #102
20170043040
2017-02-16

Aptamer-mRNA conjugates for targeted protein or peptide expression and methods for their use

 #103
20170004254
2017-01-05

Multi-targeting short interfering RNAs

 #104
20160319368
2016-11-03

A Method for Identification of Anti-HIV Human miRNA Mimics and miRNA Inhibitors and Anti-HIV Pharmaceutical Compounds

 #105
20160289681
2016-10-06

RNA-BASED HIV INHIBITORS

 #106
20160281089
2016-09-29

PREVENTION OF VIRAL INFECTIVITY

 #107
20160263253
2016-09-15

Suicide contrast agents targeting HIV reservoirs for theranostic eradication

 #108
20160208261
2016-07-21

METHODS AND COMPOSITIONS FOR INHIBITING THE FUNCTION OF POLYNUCLEOTIDE SEQUENCES

 #109
20160201061
2016-07-14

Antisense-based small RNA agents targeting the Gag open reading frame of HIV-1 RNA

 #110
20160130580
2016-05-12

RNA amidates and thioamidates for RNAi

 #111
20160108404
2016-04-21

Method for inhibiting HIV replication in mammal and human cells

 #112
20160102137
2016-04-14

CROSSLINKED ANTI-HIV-1 COMPOSITIONS FOR POTENT AND BROAD NEUTRALIZATION

 #113
20160040165
2016-02-11

Compositions and methods for in vivo excision of HIV-1 proviral DNA

 #114
20160002639
2016-01-07

NUCLEIC ACIDS INVOLVED IN VIRAL INFECTION

 #115
20150368645
2015-12-24

Cell-type specific aptamer-siRNA delivery system for HIV-1 therapy

 #116
20150218564
2015-08-06

Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell

 #117
20150166998
2015-06-18

Aptamer-mRNA conjugates for targeted protein or peptide expression and methods for their use

 #118
20150152435
2015-06-04

Method for expression of small RNA molecules within a cell

 #119
20150118682
2015-04-30

Methods for producing interfering RNA molecules in mammalian cells and therapeutic uses for such molecules

 #120
20150105450
2015-04-16

Multi-targeting short interfering RNAs

 #121
20150105445
2015-04-16

RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)

 #122
20150072347
2015-03-12

Methods and kits for synthesis of siRNA expression cassettes

 #123
20150057331
2015-02-26

Cellular targets for HIV infection

 #124
20150045412
2015-02-12

Use of the chromosome 19 microRNA cluster (C19MC) for treating viral disease and promoting authophagy

 #125
20140378526
2014-12-25

DESIGN OF NUCLEIC ACID BINDING MOLECULES WITH NON-WATSON CRICK AND NON-CANONICAL PAIRING BASED ON ARTIFICIAL MUTATION CONSENSUS SEQUENCES TO COUNTER ESCAPE MUTATIONS

 #126
20140371137
2014-12-18

PREPARATION OF PNA-6-AMINOGLUCOSAMINE CONJUGATES AS ANTIVIRAL AGENTS

 #127
20140303237
2014-10-09

Auto-recognizing therapeutic RNA/DNA chimeric nanoparticles (NP)

 #128
20140206751
2014-07-24

Methods for producing interfering RNA molecules in mammalian cells and therapeutic uses for such molecules

 #129
20140148499
2014-05-29

METHODS AND REAGENTS FOR EFFICIENT CONTROL OF HIV PROGRESSION

 #130
20130338215
2013-12-19

Composition and method for oligonucleotide delivery

 #131
20130303589
2013-11-14

RNAI molecules with non-watson crick pairing based on artificial mutation consensus sequences to counter escape mutations

 #132
20130295615
2013-11-07

Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell

 #133
20130274141
2013-10-17

Methods and kits for synthesis of siRNA expression cassettes

 #134
20130116305
2013-05-09

METHODS AND COMPOSITIONS FOR THE INHIBITION OF HIV-1 REPLICATION

 #135
20130022538
2013-01-24

Aptamer-mRNA conjugates for targeted protein or peptide expression and methods for their use

 #136
20120301449
2012-11-29

RNA interference target for treating AIDS

 #137
20120276071
2012-11-01

Anti-HIV group I introns and uses thereof in treating HIV infections

 #138
20120258534
2012-10-11

METHOD OF DELIVERING RNA INTERFERENCE AND USES THEREOF

 #139
20120238022
2012-09-20

INDUCIBLE SYSTEMS AND METHODS FOR CONTROLLING siRNA EXPRESSION

 #140
20120095082
2012-04-19

Use of interfering rna for treating an hiv infection

 #141
20120095080
2012-04-19

METHODS FOR PRODUCING INTERFERING RNA MOLECULES IN MAMMALIAN CELLS AND THERAPEUTIC USES FOR SUCH MOLECULES

 #142
20120058522
2012-03-08

Adenoviral VA1 Pol III expression system for RNAi expression

 #143
20120058092
2012-03-08

PROCESS FOR THE PREPARATION OF A COMPOSITION OF GENETICALLY MODIFIED HEMATOPOIETIC PROGENITOR CELLS

 #144
20120053228
2012-03-01

Splice-region antisense composition and method

 #145
20120046343
2012-02-23

Multi-targeting short interfering RNAs

 #146
20120041184
2012-02-16

RNA INTERFERENCE MEDIATED INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

 #147
20120034189
2012-02-09

MEANS AND METHODS FOR DURABLE INHIBITION OF PATHOGENS

 #148
20120027791
2012-02-02

ANTISENSE COMPOUND FOR INDUCING IMMUNOLOGICAL TOLERANCE

 #149
20110318838
2011-12-29

Cell-type specific aptamer-siRNA delivery system for HIV-1 therapy

 #150
20110245329
2011-10-06

DOUBLE-STRANDED RNA STRUCTURES AND CONSTRUCTS, AND METHODS FOR GENERATING AND USING THE SAME

 #151
20110243904
2011-10-06

RNA INTERFERENCE TARGET FOR TREATING AIDS

 #152
20110217769
2011-09-08

Cell-type specific aptamer-siRNA delivery system for HIV-1 therapy

 #153
20110217362
2011-09-08

Group of nucleic acid fragments for prevention of HIV infection or AIDS and the usage thereof

 #154
20110217361
2011-09-08

Group of nucleic acid fragments for prevention of HIV infection or AIDS and the usage thereof

 #155
20110217326
2011-09-08

Method for diagnosing and/or treating tumor

 #156
20110217274
2011-09-08

METHODS FOR PRODUCTION AND USES OF MULTIPOTENT ,PLURIPOTENT, DIFFERENTIATED AND DISEASE-RESISTANT CELL POPULATIONS

 #157
20110195078
2011-08-11

TAT-BASED IMMUNOMODULATORY COMPOSITIONS AND METHODS FOR THEIR DISCOVERY AND USE

 #158
20110189264
2011-08-04

Group of nucleic acid fragments for prevention of HIV infection or AIDS and the usage thereof

 #159
20110171287
2011-07-14

Use of Oligonucleotides with Modified Bases as Antiviral Agents

 #160
20110117188
2011-05-19

Group of nucleic acid fragments for prevention of HIV infection or AIDS and the usage thereof

 #161
20110098200
2011-04-28

Methods using dsdna to mediate rna interference (rnai)

 #162
20110065087
2011-03-17

NOVEL HIV TARGETS

 #163
20110059531
2011-03-10

Method for expression of small RNA molecules within a cell

 #164
20110046208
2011-02-24

Nucleolar targeting of therapeutics against HIV

 #165
20110015251
2011-01-20

RNA interference mediated inhibition of human immunodeficiency virus (HIV) gene expression using short interfering nucleic acid (siNA)

 #166
20110003381
2011-01-06

VIRAL VECTORS AND HOST CELLS AND METHODS OF MAKING AND USING THEM

 #167
20110003307
2011-01-06

Methods for producing interfering RNA molecules in mammalian cells and therapeutic uses for such molecules

 #168
20100267146
2010-10-21

Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell

 #169
20100184207
2010-07-22

Methods for producing interfering RNA molecules in mammalian cells and therapeutic uses for such molecules

 #170
20100184205
2010-07-22

Nucleic acids involved in viral infection

 #171
20100172976
2010-07-08

METHODS AND COMPOSITIONS FOR INHIBITING THE FUNCTION OF POLYNUCLEOTIDE SEQUENCES

 #172
20100168208
2010-07-01

RNA interference mediated treatment of alzheimer's disease using short interfering nucleic acid (siNA)

 #173
20100048675
2010-02-25

miRNA triplex formations for the downregulation of viral replication

 #174
20100029747
2010-02-04

METHODS AND COMPOSITIONS FOR INHIBITING THE FUNCTION OF POLYNUCLEOTIDE SEQUENCES

 #175
20090326043
2009-12-31

Method and Compound for Antiviral (HIV) Therapy

 #176
20090264504
2009-10-22

RNA INTERFERENCE MEDIATED INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

 #177
20090247612
2009-10-01

PREVENTION OF VIRAL INFECTIVITY

 #178
20090239816
2009-09-24

Multitargeting Interfering RNAs And Methods Of Their Use And Design

 #179
20090227659
2009-09-10

Nucleolar targeting of therapeutics against HIV

 #180
20090227509
2009-09-10

MODULATION OF HIV REPLICATION BY RNA INTERFERENCE

 #181
20090215860
2009-08-27

COMPOSITIONS AND METHODS FOR REGULATING GENE TRANSCRIPTION

 #182
20090192104
2009-07-30

RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)

 #183
20090192103
2009-07-30

Multitargeting interfering RNAs having two active strands and methods for their design and use

 #184
20090176727
2009-07-09

DOUBLE-STRANDED RNA STRUCTURES AND CONSTRUCTS, AND METHODS FOR GENERATING AND USING THE SAME

 #185
20090156528
2009-06-18

RNA interference mediated inhibition of hepatitis C virus (HCV) gene expression using short interfering nucleic acid (siNA)

 #186
20090149407
2009-06-11

RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)

 #187
20090148944
2009-06-11

Cell-type specific aptamer-siRNA delivery system for HIV-1 Therapy

 #188
20090111977
2009-04-30

Antisense compound for inducing immunological tolerance

 #189
20090099119
2009-04-16

RNA INTERFERENCE MEDIATED INHIBITION OF RAS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

 #190
20090099118
2009-04-16

RNA interference mediated inhibition of Stearoyl-CoA desaturase (SCD) gene expression using short interfering nucelic acid (siNA)

 #191
20090099115
2009-04-16

RNA interference mediated inhibition of MYC and/or MYB gene expression using short interfering nucleic acid (siNA)

 #192
20090088562
2009-04-02

Oligonucleotide analogs having cationic intersubunit linkages

 #193
20090042207
2009-02-12

INTRACELLULAR EXPRESSION AND DELIVERY OF siRNAs IN MAMMALIAN CELLS

 #194
20090004719
2009-01-01

Human immunodeficiency virus integrase—Transportin—SR protein—protein interactions

 #195
20080274995
2008-11-06

Suppression of nuclear factor-κB dependent processes using oligonucleotides

 #196
20080274991
2008-11-06

Nucleic Acids Against Viruses, in Particular Hiv

 #197
20080248564
2008-10-09

Property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses

 #198
20080242632
2008-10-02

Multi-targeting short interfering RNAs

 #199
20080242602
2008-10-02

Methods and compositions for the inhibition of HIV-1 replication

 #200
20080227160
2008-09-18

Circular DNA vectors for synthesis of RNA and DNA

 #201
20080194514
2008-08-14

Methods and Compositions for Inhibiting the Function of Polynucleotide Sequences

 #202
20080188430
2008-08-07

RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)

 #203
20080188428
2008-08-07

BIOINFORMATICALLY DETECTABLE GROUP OF NOVEL HIV REGULATORY GENES AND USES THEREOF

 #204
20080187993
2008-08-07

METHOD AND ANTISENSE COMPOSITION FOR SELECTIVE INHIBITION OF HIV INFECTION IN HEMATOPOIETIC CELLS

 #205
20080155703
2008-06-26

Tat-based immunomodulatory compositions and methods of their discovery and use

 #206
20080153737
2008-06-26

Method of delivering RNA interference and uses thereof

 #207
20080134352
2008-06-05

Method for producing transgenic rats

 #208
20080131940
2008-06-05

Target Cell-Specific Short Interfering Rna and Methods of Use Thereof

 #209
20080108581
2008-05-08

Compounds and Their Use for Specific and Simultaneous Inhibition of Genes Involved In Diseases and Related Drugs

 #210
20080108139
2008-05-08

COMPOSITION OF MATTER COMPRISING PRIMARY NUCLEIC ACID COMPONENT

 #211
20080081795
2008-04-03

Suppression of nuclear factor-κB dependent processes using oligonucleotides

 #212
20080081792
2008-04-03

Methods and compositions for inhibiting the function of polynucleotide sequences

 #213
20080044394
2008-02-21

Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells

 #214
20080033156
2008-02-07

Polycationic compositions for cellular delivery of polynucleotides

 #215
20080032944
2008-02-07

Target Nucleic Acid Of Retrovirus Integration

 #216
20080032942
2008-02-07

RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)

 #217
20080003682
2008-01-03

Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell

 #218
20080003658
2008-01-03

Method for expression of small antiviral RNA molecules within a cell

 #219
20070275919
2007-11-29

RNA amidates and thioamidates for RNAi

 #220
20070269815
2007-11-22

Multitargeting interfering RNAs having two active strands and methods for their design and use

 #221
20070238691
2007-10-11

Inhibition of HIV replication and expression of p24 with eIF-5A

 #222
20070238178
2007-10-11

Methods and compositions for inhibiting the function of polynucleotide sequences

 #223
20070232557
2007-10-04

Methods and compositions for inhibiting the function of polynucleotide sequences

 #224
20070219151
2007-09-20

Methods and compositions for inhibiting the function of polynucleotide sequences

 #225
20070161596
2007-07-12

RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA)

 #226
20070093437
2007-04-26

Rna interference mediated inhibition of xiap gene expression using short interfering nucleic acid (sina)

 #227
20070087335
2007-04-19

Human microRNA targets in HIV genome and a method of identification thereof

 #228
20070082862
2007-04-12

Novel antisense oligonucleotide and anti-hiv agent

 #229
20070042381
2007-02-22

Bioinformatically detectable group of novel regulatory viral and viral associated oligonucleotides and uses thereof

 #230
20070037764
2007-02-15

Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells

 #231
20070031823
2007-02-08

Vaccinia virus-related nucleic acids and microRNA

 #232
20060293262
2006-12-28

Inhibition of gene expression using RNA interfering agents

 #233
20060287268
2006-12-21

Splice-region antisense composition and method

 #234
20060269518
2006-11-30

Small interference RNA gene therapy

 #235
20060217326
2006-09-28

Group of nucleic acid fragments for prevention of HIV infection or AIDS and the usage thereof

 #236
20060205070
2006-09-14

HIV TEV compositions and methods of use

 #237
20060142225
2006-06-29

RNA interference mediated inhibition of cyclin dependent kinase-2 (CDK2) gene expression using short interfering nucleic acid (siNA)

 #238
20060122139
2006-06-08

Inducible systems and methods for controlling siRNA expression

 #239
20060104956
2006-05-18

Methods and compositions for inhibiting the function of polynucleotide sequences

 #240
20060035344
2006-02-16

Double-stranded rna structures and constructs, and methods for generating and using the same

 #241
20060034860
2006-02-16

Human immunodeficiency virus integrase-LEDGF p75 isoform protein-protein interactions

 #242
20060024321
2006-02-02

HIV antisense proteins

 #243
20050288242
2005-12-29

RNA interference mediated inhibition of RAS gene expression using short interfering nucleic acid (siNA)

 #244
20050256068
2005-11-17

RNA interference mediated inhibition of stearoyl-CoA desaturase (SCD) gene expression using short interfering nucleic acid (siNA)

 #245
20050256043
2005-11-17

HIV antisense proteins

 #246
20050239202
2005-10-27

Methods and compositions for inhibiting the function of polynucleotide sequences

 #247
20050233997
2005-10-20

RNA interference mediated inhibition of matrix metalloproteinase 13 (MMP13) gene expression using short interfering nucleic acid (siNA)

 #248
20050233344
2005-10-20

RNA interference mediated inhibition of platelet derived growth factor (PDGF) and platelet derived growth factor receptor (PDGFR) gene expression using short interfering nucleic acid (siNA)

 #249
20050222400
2005-10-06

Aptamer constructs

 #250
20050222068
2005-10-06

Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells

 #251
20050222064
2005-10-06

Polycationic compositions for cellular delivery of polynucleotides

 #252
20050209179
2005-09-22

RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)

 #253
20050208482
2005-09-22

Tat-based immunomodulatory compositions and methods for their discovery and use

 #254
20050203040
2005-09-15

RNA interference mediated inhibition of vascular cell adhesion molecule (VCAM) gene expression using short interfering nucleic acid (siNA)

 #255
20050196767
2005-09-08

RNA interference mediated inhibition of GRB2 associated binding protein (GAB2) gene expression using short interfering nucleic acis (siNA)

 #256
20050191638
2005-09-01

RNA interference mediated treatment of polyglutamine (polyQ) repeat expansion diseases using short interfering nucleic acid (siNA)

 #257
20050191618
2005-09-01

RNA interference mediated inhibition of human immunodeficiency virus (HIV) gene expression using short interfering nucleic acid (siNA)

 #258
20050187174
2005-08-25

RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)

 #259
20050182010
2005-08-18

Antiviral therapy on the basis of RNA interference

 #260
20050182009
2005-08-18

RNA interference mediated inhibition of NF-Kappa B / REL-A gene expression using short interfering nucleic acid (siNA)

 #261
20050176666
2005-08-11

RNA interference mediated inhibition of GPRA and AAA1 gene expression using short interfering nucleic acid (siNA)

 #262
20050176664
2005-08-11

RNA interference mediated inhibition of cholinergic muscarinic receptor (CHRM3) gene expression using short interfering nucleic acid (siNA)

 #263
20050176663
2005-08-11

RNA interference mediated inhibition of protein tyrosine phosphatase type IVA (PRL3) gene expression using short interfering nucleic acid (siNA)

 #264
20050176025
2005-08-11

RNA interference mediated inhibition of B-cell CLL/Lymphoma-2 (BCL-2) gene expression using short interfering nucleic acid (siNA)

 #265
20050176024
2005-08-11

RNA interference mediated inhibition of epidermal growth factor receptor (EGFR) gene expression using short interfering nucleic acid (siNA)

 #266
20050171040
2005-08-04

RNA interference mediated inhibition of cholesteryl ester transfer protein (CEPT) gene expression using short interfering nucleic acid (siNA)

 #267
20050170371
2005-08-04

RNA interference mediated inhibition of 5-alpha reductase and androgen receptor gene expression using short interfering nucleic acid (siNA)

 #268
20050164968
2005-07-28

RNA interference mediated inhibition of ADAM33 gene expression using short interfering nucleic acid (siNA)

 #269
20050164967
2005-07-28

RNA interference mediated inhibition of platelet-derived endothelial cell growth factor (ECGF1) gene expression using short interfering nucleic acid (siNA)

 #270
20050164966
2005-07-28

RNA interference mediated inhibition of type 1 insulin-like growth factor receptor gene expression using short interfering nucleic acid (siNA)

 #271
20050159382
2005-07-21

RNA interference mediated inhibition of polycomb group protein EZH2 gene expression using short interfering nucleic acid (siNA)

 #272
20050159381
2005-07-21

RNA interference mediated inhibition of chromosome translocation gene expression using short interfering nucleic acid (siNA)

 #273
20050159380
2005-07-21

RNA interference mediated inhibition of angiopoietin gene expression using short interfering nucleic acid (siNA)

 #274
20050159379
2005-07-21

RNA interference mediated inhibition of gastric inhibitory polypeptide (GIP) and gastric inhibitory polypeptide receptor (GIPR) gene expression using short interfering nucleic acid (siNA)

 #275
20050159378
2005-07-21

RNA interference mediated inhibition of Myc and/or Myb gene expression using short interfering nucleic acid (siNA)

 #276
20050158735
2005-07-21

RNA interference mediated inhibition of proliferating cell nuclear antigen (PCNA) gene expression using short interfering nucleic acid (siNA)

 #277
20050153916
2005-07-14

RNA interference mediated inhibition of telomerase gene expression using short interfering nucleic acid (siNA)

 #278
20050143333
2005-06-30

RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (SINA)

 #279
20050130181
2005-06-16

RNA interference mediated inhibition of wingless gene expression using short interfering nucleic acid (siNA)

 #280
20050124569
2005-06-09

RNA interference mediated inhibition of CXCR4 gene expression using short interfering nucleic acid (siNA)

 #281
20050124567
2005-06-09

RNA interference mediated inhibition of TRPM7 gene expression using short interfering nucleic acid (siNA)

 #282
20050124566
2005-06-09

RNA interference mediated inhibition of myostatin gene expression using short interfering nucleic acid (siNA)

 #283
20050119211
2005-06-02

RNA mediated inhibition connexin gene expression using short interfering nucleic acid (siNA)

 #284
20050080031
2005-04-14

Nucleic acid treatment of diseases or conditions related to levels of Ras, HER2 and HIV

 #285
20050079610
2005-04-14

RNA interference mediated inhibition of Fos gene expression using short interfering nucleic acid (siNA)

 #286
20050075304
2005-04-07

RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)

 #287
20050074887
2005-04-07

Adenoviral VA1 Pol III promoter system for RNAi expression

 #288
20050063958
2005-03-24

Process for the preparation of a composition of genetically modified hematopoietic progenitor cells

 #289
20050054596
2005-03-10

RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)

 #290
20050042620
2005-02-24

RNA catalyst for cleaving specific RNA sequences

 #291
20050038238
2005-02-17

Oligonucleotide complexes for use as anti-viral therapeutics

 #292
20050032733
2005-02-10

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SiNA)

 #293
16360876
2020-04-28

Vaccine to pathogenic immune activation cells during infections

 #294
10243817
2016-02-23

Method for producing transgenic animals

 #295
10135545
2014-07-01

HIV antisense proteins

 #296
8978633
2014-09-30

Non-ionically bound constructs, and compositions and kits comprising domains